In-silico Drug Designing and Development for Genetic Disorders- A Review
Genetic disorders arise from pathogenic genomic alterations that disrupt essential cellular, biochemical, and physiological functions, collectively imposing a substantial global health burden. Conventional drug discovery for inherited diseases is challenged by complex molecular defects, including loss- or gain-of-funct...